Crossmark Global Holdings Inc. Purchases 19,913 Shares of CVS Health Corporation (NYSE:CVS)

Crossmark Global Holdings Inc. lifted its stake in CVS Health Corporation (NYSE:CVS - Free Report) by 6.7% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 316,438 shares of the pharmacy operator's stock after buying an additional 19,913 shares during the quarter. Crossmark Global Holdings Inc.'s holdings in CVS Health were worth $21,439,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Essex Financial Services Inc. lifted its holdings in CVS Health by 0.8% during the 1st quarter. Essex Financial Services Inc. now owns 20,705 shares of the pharmacy operator's stock worth $1,403,000 after buying an additional 166 shares in the last quarter. McIlrath & Eck LLC raised its position in shares of CVS Health by 32.6% during the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after acquiring an additional 174 shares during the last quarter. Koshinski Asset Management Inc. lifted its stake in shares of CVS Health by 3.7% during the first quarter. Koshinski Asset Management Inc. now owns 4,930 shares of the pharmacy operator's stock valued at $334,000 after acquiring an additional 178 shares during the period. Horizon Bancorp Inc. IN boosted its holdings in CVS Health by 7.4% in the first quarter. Horizon Bancorp Inc. IN now owns 2,610 shares of the pharmacy operator's stock valued at $177,000 after acquiring an additional 180 shares during the last quarter. Finally, Coppell Advisory Solutions LLC raised its holdings in CVS Health by 17.3% during the 4th quarter. Coppell Advisory Solutions LLC now owns 1,282 shares of the pharmacy operator's stock worth $56,000 after purchasing an additional 189 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.

Insider Transactions at CVS Health

In other CVS Health news, Director Guy P. Sansone acquired 1,570 shares of the company's stock in a transaction on Thursday, June 5th. The shares were purchased at an average price of $63.70 per share, for a total transaction of $100,009.00. Following the completion of the purchase, the director directly owned 12,007 shares of the company's stock, valued at approximately $764,845.90. This represents a 15.04% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.22% of the company's stock.

CVS Health Stock Down 1.6%

Shares of CVS stock traded down $1.08 on Thursday, hitting $65.58. 6,326,225 shares of the stock were exchanged, compared to its average volume of 10,799,038. The firm has a market capitalization of $82.96 billion, a P/E ratio of 15.65, a price-to-earnings-growth ratio of 0.96 and a beta of 0.57. CVS Health Corporation has a fifty-two week low of $43.56 and a fifty-two week high of $72.51. The business has a 50-day moving average of $65.18 and a 200 day moving average of $61.93. The company has a current ratio of 0.82, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77.

CVS Health (NYSE:CVS - Get Free Report) last released its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, beating analysts' consensus estimates of $1.62 by $0.63. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The business had revenue of $94.59 billion during the quarter, compared to the consensus estimate of $93.07 billion. During the same quarter last year, the firm earned $1.31 earnings per share. The firm's revenue for the quarter was up 7.0% compared to the same quarter last year. Equities analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 1st. Stockholders of record on Tuesday, July 22nd will be paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.06%. The ex-dividend date is Tuesday, July 22nd. CVS Health's dividend payout ratio is currently 63.48%.

Analysts Set New Price Targets

CVS has been the topic of several recent research reports. Truist Financial raised their target price on shares of CVS Health from $82.00 to $84.00 and gave the company a "buy" rating in a research note on Monday, May 12th. Wells Fargo & Company reaffirmed an "overweight" rating and issued a $84.00 price objective (up from $76.00) on shares of CVS Health in a research note on Tuesday, May 6th. Royal Bank Of Canada upped their target price on shares of CVS Health from $74.00 to $81.00 and gave the company an "outperform" rating in a research report on Monday, May 5th. Robert W. Baird raised their price target on CVS Health from $51.00 to $71.00 and gave the stock a "neutral" rating in a research report on Tuesday, April 15th. Finally, Morgan Stanley reiterated an "overweight" rating on shares of CVS Health in a report on Tuesday, April 15th. Two research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, CVS Health presently has a consensus rating of "Moderate Buy" and a consensus price target of $75.06.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.